0001209191-23-040024.txt : 20230628 0001209191-23-040024.hdr.sgml : 20230628 20230628160112 ACCESSION NUMBER: 0001209191-23-040024 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230628 FILED AS OF DATE: 20230628 DATE AS OF CHANGE: 20230628 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Legorreta Pablo G. CENTRAL INDEX KEY: 0001507678 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39329 FILM NUMBER: 231052074 MAIL ADDRESS: STREET 1: 110 E 59TH STREET STREET 2: SUITE 3300 CITY: NEW YORK STATE: NY ZIP: 10022 FORMER NAME: FORMER CONFORMED NAME: Legorreta Pablo DATE OF NAME CHANGE: 20101213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Royalty Pharma plc CENTRAL INDEX KEY: 0001802768 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 110 EAST 59TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 883-0200 MAIL ADDRESS: STREET 1: 110 EAST 59TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-28 0 0001802768 Royalty Pharma plc RPRX 0001507678 Legorreta Pablo G. C/O ROYALTY PHARMA PLC 110 E. 59TH STREET NEW YORK NY 10022 1 1 1 0 CEO, Chairman of the Board 0 Class A ordinary shares 2023-06-28 4 P 0 130000 29.5136 A 600000 I By Legorreta 2023 SR Trust Class A ordinary shares 63795 D Class A ordinary shares 460139 I By Legorreta Investments LLC Class A ordinary shares 1284590 I By GST-Exempt Legorreta 2012 Family Trust Class A ordinary shares 41306 I By GST-Exempt Legorreta 2020 Family Trust Class A ordinary shares 10000 I By Child Class A ordinary shares 10000 I By Child Class A ordinary shares 123310 I By IRRA Class A ordinary shares 118500 I By SEP/IRA Class A ordinary shares 1040410 I By Legorreta Children 2002 Trust Class A ordinary shares 6930 I By Spouse Represents shares acquired by the reporting person in open market transactions as part of the reporting person's previously disclosed intention to purchase up to $50 million of the issuer's Class A ordinary shares, as announced in the issuer's press release on March 27, 2023 regarding the issuer's $1.0 billion share repurchase program. The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $29.40 to $29.60. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range. /s/ Sean Weisberg, as Attorney-in-Fact for Pablo G. Legorreta 2023-06-28